HOWL logo

Werewolf Therapeutics (HOWL)

Profile

Full Name

Werewolf Therapeutics, Inc.

Ticker Symbol

HOWL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 30, 2021

Indexes

Not included

Website

http://werewolftx.com

Employees

46

Key Details

Price

$0.92(+8.37%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.89M(-90.55% YoY)

Annual EPS

-$1.63(-55.24% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.92
HOWL price is $0.92

30-Day Relative Volume

0.63
HOWL 30-day relative volume is 0.63

Price Performance

Price Most recent change

+8.37%
HOWL price was up +8.37% on Apr 17, 2025

Price YTD change

-37.91%
HOWL price is down -37.91% since January 1st

Price 1-year change

-84.26%
HOWL price is down -84.26% year-on-year

Price 3-year change

-79.98%
HOWL price is down -79.98% over the past 3 years

Price Range

Price All-time high

$23.99
HOWL price is currently -96.17% below its historical high of $23.99

Price 3-year low

$0.59
HOWL price is currently +54.45% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$41.20M
HOWL market capitalization is $41.20 million

Market cap 3-year change

-67.54%
HOWL market capitalization is down -67.54% over the past 3 years

Market cap All-time high

$559.91M
HOWL market capitalization is currently -92.64% below its historical high of $559.91 million

Market cap sector rank

34.98%
HOWL market capitalization is higher than 34.98% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.41%
HOWL shares outstanding is up +3.41% year-on-year

Shares Outstanding 3-Year Change

+62.1%
HOWL shares outstanding is up +62.1% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.65
HOWL beta is 1.65

200-day SMA

$1.81
HOWL price is currently -49.27% below its 200-day simple moving average

50-day SMA

$1.12
HOWL price is currently -18.15% below its 50-day simple moving average

RSI

49.25
HOWL 14-day relative strength index is 49.25

Volume

0.63
HOWL 30-day relative volume is 0.63

ATR

$0.11
HOWL average true range is $0.11

10-day Historical Volatility

152.95%
HOWL 10-day historical volatility is 152.95%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.89M
HOWL annual revenue is $1.89 million

Revenue Analysts estimate

$1.20M
HOWL annual revenue is currently +57.08% higher than the consensus analysts' forecast

Revenue 1-year change

-90.55%
HOWL annual revenue is down -90.55% year-on-year

Revenue Sector rank

15.13%
HOWL annual revenue is higher than 15.13% of companies in Healthcare sector

EPS

EPS

-$1.63
HOWL annual earnings per share is -$1.63

EPS Analysts estimate

-$1.74
HOWL annual earnings per share is currently -6.32% lower than the consensus analysts' forecast

EPS 1-year change

-55.24%
HOWL annual earnings per share is down -55.24% year-on-year

EPS Sector rank

42.75%
HOWL annual earnings per share is higher than 42.75% of companies in Healthcare sector

Profit

Gross profit

-
HOWL annual gross profit value is unknown

Gross margin

-
HOWL annual gross profit margin value is unknown

Operating profit

-$73.59M
HOWL annual operating income is -$73.59 million

Operating margin

-3904.19%
HOWL annual operating profit margin is -3904.19%

Net income

-$70.52M
HOWL annual net profit is -$70.52 million

Net margin

-3740.85%
HOWL annual net profit margin is -3740.85%

Expenses

Total expenses

$75.48M
HOWL annual total expenses is $75.48 million

Operating expenses

$75.48M
HOWL annual total operating expenses is $75.48 million

Cost of goods sold

-
HOWL annual cost of goods sold value is unknown

Selling, general & administrative expenses

$19.05M
HOWL annual SGA is $19.05 million

Depreciation and amortization

$1.81M
HOWL annual depreciation & amortization is $1.81 million

Interest expense

$4.66M
HOWL annual interest expense is $4.66 million

Income tax

-
HOWL annual income tax value is unknown

EBIT & EBITDA

EBIT

-$65.86M
HOWL annual earnings before interest & taxes is -$65.86 million

EBITDA

-$64.05M
HOWL annual EBITDA is -$64.05 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$126.93M
HOWL annual total assets is $126.93 million

Non current assets

$13.86M
HOWL annual long term assets is $13.86 million

Current assets

$113.07M
HOWL annual total current assets is $113.07 million

Cash and cash equivalents

$111.00M
HOWL annual cash & cash equivalents is $111.00 million

Accounts receivable

-
HOWL annual accounts receivable value is unknown

Inventory

-
HOWL annual inventory value is unknown

Liabilities

Total liabilities

$53.54M
HOWL annual total liabilities is $53.54 million

Long term liabilities

$38.36M
HOWL annual total long term liabilities is $38.36 million

Current liabilities

$15.18M
HOWL annual total current liabilities is $15.18 million

Accounts payable

$3.04M
HOWL annual accounts payable is $3.04 million

Debt

Total debt

$37.09M
HOWL annual total debt is $37.09 million

Total debt 1-year change

-28.57%
HOWL annual total debt is down -28.57% year-on-year

Long term debt

$35.53M
HOWL annual long term debt is $35.53 million

Short term debt

$1.56M
HOWL annual short term debt is $1.56 million

Equity & Capital

Shareholders equity

$73.39M
HOWL annual stockholders equity is $73.39 million

Book value

$73.39M
HOWL annual book value is $73.39 million

Retained earnings

-$414.59M
HOWL annual retained earnings is -$414.59 million

Working capital

$97.89M
HOWL annual working capital is $97.89 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$56.19M
HOWL annual cash flow from operations is -$56.19 million

Cash from operations 1-year change

-72.29%
HOWL annual cash flow from operations is down -72.29% year-on-year

Cash from investing

-$254.00K
HOWL annual cash flow from investing activities is -$254.00 thousand

Cash from investing 1-year change

+66.97%
HOWL annual cash flow from investing activities is up +66.97% year-on-year

Cash from financing

$13.08M
HOWL annual cash flow from financing activities is $13.08 million

Cash from financing 1-year change

-77.61%
HOWL annual cash flow from financing activities is down -77.61% year-on-year

CAPEX

CAPEX

$254.00K
HOWL annual capital expenditures is $254.00 thousand

CAPEX 1-year change

-66.97%
HOWL annual capital expenditures is down -66.97% year-on-year

Free Cash Flow

Free cash flow

-$56.44M
HOWL annual free cash flow is -$56.44 million

Free cash flow 1-year change

-69.08%
HOWL annual free cash flow is down -69.08% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
HOWL annual gross profit margin value is unknown

Operating margin

-3904.19%
HOWL annual operating profit margin is -3904.19%

Net margin

-3740.85%
HOWL annual net profit margin is -3740.85%

ROA & ROE

ROA

-46.74%
HOWL annual return on assets is -46.74%

ROE

-76.33%
HOWL annual return on equity is -76.33%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
HOWL price to earnings ratio value is unknown

PE ratio Sector rank

-
HOWL price to earnings ratio is unknown

PB Ratio

PB ratio

0.56
HOWL price to book ratio is 0.56

PB ratio Sector rank

31.57%
HOWL price to book ratio is higher than 31.57% of companies in Healthcare sector

PS Ratio

PS ratio

-
HOWL price to sales ratio value is unknown

PS ratio Sector rank

-
HOWL price to sales ratio is unknown

Enterprise value

Enterprise value

-$32.71M
HOWL enterprise value is -$32.71 million

Enterprise value Sector rank

2.48%
HOWL enterprise value is higher than 2.48% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.51
HOWL EV/EBITDA is 0.51

EV/EBITDA Sector rank

72.41%
HOWL EV/EBITDA is higher than 72.41% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.45
HOWL annual current ratio is 7.45

Quick ratio

-
HOWL annual quick ratio value is unknown

Leverage

Debt to equity

0.36
HOWL annual debt to equity ratio is 0.36

Interest coverage ratio

-14.14
HOWL annual interest coverage ratio is -14.14

Risk & Stability

Piotroski F-Score

-
HOWL piotroski f-score value is unknown

Altman Z-Score

-4.88
HOWL altman z-score is -4.88

Analyst ratings

Recent major analysts updates

Mar 12, 25 Wedbush
Outperform
Mar 12, 25 HC Wainwright & Co.
Buy
Jan 14, 25 JMP Securities
Market Outperform
Nov 19, 24 HC Wainwright & Co.
Buy
Jul 2, 24 HC Wainwright & Co.
Buy
Jun 26, 24 JMP Securities
Market Outperform
Jun 26, 24 HC Wainwright & Co.
Buy
Jun 4, 24 JMP Securities
Market Outperform
Jun 3, 24 HC Wainwright & Co.
Buy
May 24, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

OKYO logo
OKYO Pharma Limited (OKYO)
CNTB logo
Connect Biopharma Holdings Limited (CNTB)
ANEB logo
Anebulo Pharmaceuticals (ANEB)
KPTI logo
Karyopharm Therapeutics (KPTI)
BLUE logo
bluebird bio (BLUE)
OPGN logo
OpGen (OPGN)
SPRO logo
Spero Therapeutics (SPRO)
CAMP logo
CAMP4 Therapeutics (CAMP)
Pheton Holdings Ltd Class A (PTHL)
  • What is the ticker symbol for Werewolf Therapeutics?
  • Does Werewolf Therapeutics pay dividends?
  • What sector is Werewolf Therapeutics in?
  • What industry is Werewolf Therapeutics in?
  • What country is Werewolf Therapeutics based in?
  • When did Werewolf Therapeutics go public?
  • Is Werewolf Therapeutics in the S&P 500?
  • Is Werewolf Therapeutics in the NASDAQ 100?
  • Is Werewolf Therapeutics in the Dow Jones?
  • When was Werewolf Therapeutics's last earnings report?
  • When does Werewolf Therapeutics report earnings?
  • Should I buy Werewolf Therapeutics stock now?

What is the ticker symbol for Werewolf Therapeutics?

The ticker symbol for Werewolf Therapeutics is NASDAQ:HOWL

Does Werewolf Therapeutics pay dividends?

No, Werewolf Therapeutics does not pay dividends

What sector is Werewolf Therapeutics in?

Werewolf Therapeutics is in the Healthcare sector

What industry is Werewolf Therapeutics in?

Werewolf Therapeutics is in the Biotechnology industry

What country is Werewolf Therapeutics based in?

Werewolf Therapeutics is headquartered in United States

When did Werewolf Therapeutics go public?

Werewolf Therapeutics's initial public offering (IPO) was on April 30, 2021

Is Werewolf Therapeutics in the S&P 500?

No, Werewolf Therapeutics is not included in the S&P 500 index

Is Werewolf Therapeutics in the NASDAQ 100?

No, Werewolf Therapeutics is not included in the NASDAQ 100 index

Is Werewolf Therapeutics in the Dow Jones?

No, Werewolf Therapeutics is not included in the Dow Jones index

When was Werewolf Therapeutics's last earnings report?

Werewolf Therapeutics's most recent earnings report was on Mar 11, 2025

When does Werewolf Therapeutics report earnings?

The next expected earnings date for Werewolf Therapeutics is May 2, 2025

Should I buy Werewolf Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page